Seminars in Dialysis

Introduction
pp. 267-268(2)
Author: Robert, Reilly

Anemia Management in Chronic Kidney Disease: What Have We Learned after 17 Years?
pp. 269-272(4)
Author: Spiegel, David M.

Erythropoietin Resistance in the Treatment of the Anemia of Chronic Renal Failure
pp. 273-278(6)
Authors: Priyadarshi, Anumeet; Shapiro, Joseph I.

Nonhematologic Complications of Erythropoietin Therapy
pp. 279-284(6)
Authors: Zhu, Xiaolei; Perazella, Mark A.

Intravenous Iron Therapy in End-Stage Renal Disease
pp. 285-290(6)
Author: Brewster, Ursula C.

Neutrophil Dysfunction and Infection Risk in End-Stage Renal Disease
pp. 291-296(6)
Author: Chonchol, Michel

When Heparin Causes Thrombosis: Significance, Recognition, and Management of Heparin-Induced Thrombocytopenia in Dialysis Patients
pp. 297-304(8)
Authors: Chang, John Jae Young; Parikh, Chirag R.

The Safety of Heparins in End-Stage Renal Disease
pp. 305-310(6)
Authors: Sonawane, Samsher; Kasbekar, Nishaminy; Berns, Jeffrey S.

Anticoagulation and Continuous Renal Replacement Therapy
pp. 311-316(6)
Authors: Amanzadeh, Jamshid; Reilly, Robert F.

Platelet Dysfunction and End-Stage Renal Disease
pp. 317-322(6)
Authors: Kaw, Dinkar; Malhotra, Deepak

Dialysis-Related Carnitine Disorder
pp. 323-328(6)
Author: Hedayati, S. Susan

Multiple Myeloma in End-Stage Renal Disease
pp. 329-334(6)
Author: Penfield, Jeffrey G.

Vascular Access Thrombosis Prophylaxis
pp. 335-342(8)
Author: Choudhury, Devasmita

News and Update
pp. 343-345(3)

Briefly Noted
pp. 347-348(2)